9997.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 11:08):

Kangji Medical Holdings Limited, through its subsidiaries, designs, develops, manufactures, and sale of minimally invasive surgical instruments and accessories in China...

Stats
Šios dienos apimtis	1.11M
Vidutinė apimtis	752 134
Rinkos kapitalizacija	8.59B
EPS	HKD0 ( 2024-03-24 )
Kita pelno data	( HKD0 ) 2024-05-27
Last Dividend	HKD0.205 ( 2023-05-30 )
Next Dividend	HKD0 ( N/A )
P/E	15.74
ATR14	HKD0.00600 (0.08%)

Tūris Koreliacija

Ilgas: 0.19 (neutral)

Trumpas: -0.67 (moderate negative)

Signal:(39.168) Neutral

Kangji Medical Holdings Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Kangji Medical Holdings Koreliacija - Valiuta/Žaliavos

0.57
( weak )

0.79
( moderate )

0.00
( neutral )

-0.34
( neutral )

0.12
( neutral )

-0.81
( strong negative )

Kangji Medical Holdings Finansinės ataskaitos

Annual	2023
Pajamos:	HKD926.02M
Bruto pelnas:	HKD741.20M (80.04 %)
EPS:	HKD0.430

FY	2023
Pajamos:	HKD926.02M
Bruto pelnas:	HKD741.20M (80.04 %)
EPS:	HKD0.430

FY	2022
Pajamos:	HKD786.37M
Bruto pelnas:	HKD635.25M (80.78 %)
EPS:	HKD0.400

FY	2021
Pajamos:	HKD690.26M
Bruto pelnas:	HKD562.93M (81.55 %)
EPS:	HKD0.373

Financial Reports:

No articles found.

Kangji Medical Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.205 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Kangji Medical Holdings Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.32 - Stable (6.48%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0440	2021-05-28
Last Dividend	HKD0.205	2023-05-30
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	HKD0.421	--
Avg. Dividend % Per Year	0.00%	--
Score	3.1	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.32
Div. Directional Score	8.55	--

Next Divdend (Est)
(2025-03-31)

HKD0.237 Estimate 3.06 %

Dividend Stability

0.24 Very Poor

Dividend Score

3.10

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6885.HK	Ex Dividend Junior	2023-09-07	Semi-Annually	0.00%
1979.HK	Ex Dividend Junior	2023-10-09	Annually	0.00%
1044.HK	Ex Dividend Knight	2023-09-18	Semi-Annually	0.00%
0119.HK	Ex Dividend Junior	2023-06-09	Sporadic	0.00%
3382.HK	Ex Dividend Junior	2023-06-19	Annually	0.00%
1587.HK	Ex Dividend Junior	2023-05-23	Annually	0.00%
0631.HK	Ex Dividend Junior	2023-06-05	Sporadic	0.00%
9919.HK	Ex Dividend Knight	2023-08-24	Semi-Annually	0.00%
2169.HK	Ex Dividend Junior	2023-06-20	Annually	0.00%
1171.HK	Ex Dividend Knight	2023-07-05	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.544	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.118	1.200	6.06	7.27	[0 - 0.3]
returnOnEquityTTM	0.138	1.500	9.58	10.00	[0.1 - 1]
payoutRatioTTM	0.429	-1.000	5.71	-5.71	[0 - 1]
currentRatioTTM	17.72	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	15.27	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	14.03	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00888	-1.500	9.85	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.359	2.00	9.88	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.284	2.00	9.86	10.00	[0 - 20]
debtEquityRatioTTM	0.0104	-1.500	9.96	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.800	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.478	1.000	2.44	2.44	[0.1 - 0.6]
cashFlowToDebtRatioTTM	11.08	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.217	0.800	-1.885	-1.508	[0.5 - 2]
Total Score				11.78

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	15.77	1.000	8.51	0	[1 - 100]
returnOnEquityTTM	0.138	2.50	9.73	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.284	2.00	9.91	10.00	[0 - 30]
dividendYielPercentageTTM	3.02	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.359	2.00	9.88	10.00	[0 - 30]
payoutRatioTTM	0.429	1.500	5.71	-5.71	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.453	1.000	1.172	0	[0.1 - 0.5]
Total Score				5.32

Kangji Medical Holdings

Kangji Medical Holdings Limited, through its subsidiaries, designs, develops, manufactures, and sale of minimally invasive surgical instruments and accessories in China. It offers disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, ultrasonic scalpels, and other types of disposable hand-held instruments; and reusable trocars, reusable forceps, and other reusable products. The company's products are used in obstetrics and gynecology, general surgery, urology, and thoracic surgery specialties. It primarily sells products to a network of distributors. The company was founded in 2004 and is headquartered in Hangzhou, China.